The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Stepanov S.O.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Vostrov A.N.

FGBU «Moskovskiĭ nauchno-issledovatelskiĭ onkologicheskiĭ institut im. P.A. Gertsena» Minzdrava Rossii

Dolgacheva D.V.

FGBU «Moskovskiĭ nauchno-issledovatelskiĭ onkologicheskiĭ institut im. P.A. Gertsena» Minzdrava Rossii

Sergeeva N.S.

Russian University of Peoples' Friendship

Novikova E.G.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena

Invasive ultrasound diagnosis in combination with monitoring the level of the marker СA125 in the early detection of recurrent ovarian cancer

Authors:

Stepanov S.O., Vostrov A.N., Dolgacheva D.V., Sergeeva N.S., Novikova E.G.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2016;5(3): 23‑26

Read: 1256 times


To cite this article:

Stepanov SO, Vostrov AN, Dolgacheva DV, Sergeeva NS, Novikova EG. Invasive ultrasound diagnosis in combination with monitoring the level of the marker СA125 in the early detection of recurrent ovarian cancer. P.A. Herzen Journal of Oncology. 2016;5(3):23‑26. (In Russ.)
https://doi.org/10.17116/onkolog20165323-26

Recommended articles:
Diaphragmatic rela­xation masquerading as COPD. Piro­gov Russian Journal of Surgery. 2025;(10-2):107-113

References:

  1. Poddubnaya I, Zhordania K, Kharitonova T, Panichenko I, Tamaeva Z. Predictive factors for recurrence at early stages of ovarian cancer. Sovremennaya onkologiya. 2005;2:76-78. (In Russ.)
  2. Bulanova I. Efficiency of clinical methods on future directions in monitoring recurrence after treatment of primary ovarian cancer. Diss. Moscow; 2006. Available at http://medical-diss.com/. Accessed October 10, 2015. (In Russ.)
  3. Korneeva I, Novikova E, Sergeeva N. A modern view on marker recurrence of ovarian cancer. Rossiiskii onkologicheskii zhurnal. 2010;2:54-57. (In Russ.)
  4. Vostrov A, Stepanov S, Korneeva I. Differential ultrasound diagnostic benign and malignant ovarian tumours. Onkologiya. Zhurnal im. P.A. Gerzena. 2015;4(3):52-58. (In Russ.)
  5. Chekalova M, Sinizina M. Features of early diagnostics recurrence of ovarian cancer by an ultrasound method. Ul'trazvukovaya i funktsional'naya diagnostika. 2007;2:40-47. (In Russ.)
  6. Rustin GJ, Marples M, Nelstrop AE, Mahmoudi M, Meyer T. Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol. 2001;19(20):4054-4057. PMID:11600607
  7. Tummala MK, McGuire WP. Ovarian cancer, CA-125 addiction, and informed confusion: much ado about less. J Clin Oncol. 2007;25(24):3570-3571. doi:10.1200/JCO.2007.11.9735.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.